secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K/A
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001601830-23-000061
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Recursion adopts annual Say-on-Pay vote after shareholder majority
------------------------------------------------------------------

- At June 16, 2023 annual meeting, majority of votes favored annual advisory Say-on-Pay votes.
- Board determined to hold annual Say-on-Pay votes until next shareholder frequency vote.
- Decision disclosed via amendment to original 8-K filed June 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000061/0001601830-23-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000061/rxrx-20230616.htm
  HTML page:      https://secwatch.observer/filing/0001601830-23-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer